The US DoJ charges sixth pharmaceutical company for fixing prices, allocating customers a bid-rigging in the ongoing investigation into the generic pharmaceutical industry (Taro Pharmaceuticals)

Sixth Pharmaceutical Company Charged In Ongoing Criminal Antitrust Investigation* Fifth Company to Admit It Fixed Prices of Generic Drugs Taro Pharmaceuticals U.S.A., Inc. (Taro U.S.A.) has been charged for conspiring to fix prices, allocate customers, and rig bids for generic drugs, the Department of Justice announced today. A two-count felony charge was filed today in the U.S. District Court for the Eastern District of Pennsylvania in Philadelphia, charging Taro U.S.A. with participating in two criminal antitrust conspiracies, each with a competing manufacturer of generic drugs and various executives. The Antitrust Division also announced a deferred prosecution agreement (DPA) resolving the charges against Taro U.S.A., under which the company agreed to pay a $205,653,218 criminal

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

US Department of Justice Antitrust Division, The US DoJ charges sixth pharmaceutical company for fixing prices, allocating customers a bid-rigging in the ongoing investigation into the generic pharmaceutical industry (Taro Pharmaceuticals), 23 juillet 2020, e-Competitions July 2020, Art. N° 95964

Visites 277

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues